Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain
Vertex stock plummeted Thursday after the company's pain drug proved it's no better than a placebo in patients with lower back and hip pain. The post Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain appeared first on Investor's Business Daily.
Vertex stock plummeted Thursday after the company's pain drug proved it's no better than a placebo in patients with lower back and hip pain.
The post Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain appeared first on Investor's Business Daily.